Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline consumer healthcare (ireland) limited - coal tar cade oil coal tar solution coal tar extract - bath additive - 25 %w/w

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline consumer healthcare (ireland) limited - coal tar cade oil coal tar solution arachis oil - shampoo - 1 %w/w

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - soya oil, quantity: 0 qs; olive oil, quantity: 0 qs - injection, emulsion - excipient ingredients: water for injections; ascorbyl palmitate; glycerol; sodium oleate; sodium hydroxide; egg lecithin - parenteral nutrition when oral or enteral nutrition is impossible, insufficient or contraindicated.

Malta - English - Medicines Authority

beecham group plc 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - coal tar, solution - cutaneous liquid - coal tar solution 1 % (w/w) - antipsoriatics

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - olive oil, quantity: 0 qs; soya oil, quantity: 0 qs - injection, emulsion - excipient ingredients: sodium oleate; egg lecithin; sodium hydroxide; glycerol; ascorbyl palmitate; water for injections - parenteral nutrition when oral or enteral nutrition is impossible, insufficient or contraindicated.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

almirall ltd - soya oil - bath additive - 847.5mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

almirall ltd - soya oil; lauromacrogols - bath additive - 829.5mg/1gram ; 150mg/1gram

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - soya oil 10%{relative};  ;   - solution for infusion - 10 % - active: soya oil 10%{relative}     excipient: egg lecithin glycerol water for injection - part of the intravenous diet in all parenteral nutrition indications including: - preoperative and postoperative nutritional disturbances where an improved nitrogen balance is required; - nutritional disorders or disturbances of nitrogen balance due to inadequate or failing intestinal absorption caused by tumours in the gastrointestinal tract, acute or chronic intestinal diseases (peritonitis, ulcerative colitis, terminal ileitis); - burns, to reduce the frequently excessive nitrogen losses; - prolonged unconsciousness, eg following cranial trauma or poisoning in cases where enteral feeding is inappropriate or impossible; - impaired renal function where a concentrated source of energy may be indicated to reduce protein breakdown; - cachexia and - patients with essential fatty acid deficiency who cannot maintain or restore a normal essential fatty acid pattern by oral intake.

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - soya oil 20%{relative};  ;   - solution for infusion - 20 % - active: soya oil 20%{relative}     excipient: egg lecithin glycerol water for injection - part of the intravenous diet in all parenteral nutrition indications including: - preoperative and postoperative nutritional disturbances where an improved nitrogen balance is required; - nutritional disorders or disturbances of nitrogen balance due to inadequate or failing intestinal absorption caused by tumours in the gastrointestinal tract, acute or chronic intestinal diseases (peritonitis, ulcerative colitis, terminal ileitis); - burns, to reduce the frequently excessive nitrogen losses; - prolonged unconsciousness, eg following cranial trauma or poisoning in cases where enteral feeding is inappropriate or impossible; - impaired renal function where a concentrated source of energy may be indicated to reduce protein breakdown; - cachexia and - patients with essential fatty acid deficiency who cannot maintain or restore a normal essential fatty acid pattern by oral intake.

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - soya oil 30%{relative};  ;   - solution for infusion - 30 % - active: soya oil 30%{relative}     excipient: egg lecithin glycerol water for injection - part of the intravenous diet in all parenteral nutrition indications including: - preoperative and postoperative nutritional disturbances where an improved nitrogen balance is required; - nutritional disorders or disturbances of nitrogen balance due to inadequate or failing intestinal absorption caused by tumours in the gastrointestinal tract, acute or chronic intestinal diseases (peritonitis, ulcerative colitis, terminal ileitis); - burns, to reduce the frequently excessive nitrogen losses; - prolonged unconsciousness, eg following cranial trauma or poisoning in cases where enteral feeding is inappropriate or impossible; - impaired renal function where a concentrated source of energy may be indicated to reduce protein breakdown; - cachexia and - patients with essential fatty acid deficiency who cannot maintain or restore a normal essential fatty acid pattern by oral intake.